No Detail Found!

Diagnostic value of different tumor markers, our experience

Author(s)
Tariq Parvez Department ol Radiotherapy Oncology, Services Hospital, Lahore.Pakistan
Muhammad Saeed Anwar Department of Pathology, P.G.M.I., Lahore., Pakistan
Abstract
Variety of tumor markers with varying sensitivity and specificity are used for diagnosis of different malignancies. This study was done to determine the diagnostic value of different tumor markers in our patients with various malignancies. Out of 235 patients studied, 162 were suffering from malignant and 73 from benign diseases. Among these 84 were positive for tumor markers. Out of these positive tumor markers, 75 were suffering from malignancy. Tumor marker analyzed were CA-15-3, CA-125, 3-HCG, CEA, PSA and oc-FP depending upon the type of the disease these cases presented. Analysis of the results revealed that different tumor markers had sensitivity varying from 76.9 - 95.8% and specificity varying from 75 - 90.9%. CA-125 was observed to be the most specific and sensitive tumor marker for ovarian tumors followed by a-FP for hepatocellular tumors and CEA for gastrointestinal tumors. Similarly, PSA for prostate cancers, 3-HCG for choriocarcinoma and CA-15-3 for breast cancer. It is concluded that all the tumor markers have a variable diagnostic value, which cannot be relied upon independently, without other tests added to increase diagnostic value.
Publication Details
Page(s) 418-420
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 10, Issue: 11, Year: 2000

Request the full text from PASTIC

Keywords
Neoplasms Tumor markers, biological CA-15-3 antigen CA-125 antigen. beta-HCG Carcino alpha-Feto proteins Prostate-specific antigen. embryonic antigen
References
Dhaka B .1995 .k new radioimmunoassay using monoclonal antibodies HMFG1 and HMFG2 togetherwith an existing markerCA-125 for the serological detection and management of epithelial ovariancancer. BrJCane, 54 : 891-5.
.1985 .Ovarian tumorantigens and othertumormarkerin text book on ovarian cancer. Oxford Univ Press, : 280-7.
.1978 .. BrMedJ, 2 : 661-3.
Roman LD .1998 .Carcinoembryonicantigen in women with isolated pelvic masses. Clinical utility? JRepoMed, 5 : 432.
Oksa H .1988 .-3 assay in the diagnosis and follow-up of breastcancer. BrJCane, 58 : 213.
.1994 .digital rectalexamination and serumprostatespecific antigen in the early detection of prostate cancer; result of muticenter clinical trial of 6,630 men. , 151 : 1283.
Smith C .1994 .CatalonaW. The nature of prostate cancer concentration measured by radioimmunoassay in detected through prostate specific antigen based the diagnosing and excluding of hepatocellular screening. JUro!, 152 : 1732.
0

Citations

0

Downloads

65

Views